Source:http://linkedlifedata.com/resource/pubmed/id/15848555
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2005-4-25
|
pubmed:abstractText |
This open-label, longitudinal, long-term study of de novo pediatric renal transplant recipients was designed to investigate the pharmacokinetics (PK) of mycophenolic acid (MPA) and its possible interaction with cyclosporine (CsA). Thirty-four children on an immunosuppressive regimen of CsA, prednisone, and mycophenolate mofetil (MMF, 300-400 mg/m2 twice daily) were investigated at 6, 30, 180, and 360 days after transplantation. Considerable interindividual variability in the areas under the concentration curve (AUC(0-12)) of MPA was observed during the follow-up, although the dose of MMF remained the same over the same time. Predose levels (C0) increased significantly during the first 6 months after transplantation: C0 at 6 and 180 days after transplantation was 0.8 +/- 0.6 and 1.9 +/- 1.1 microg/mL (P < .0001). A significant time-dependent increase in the AUC of MPA was also observed during the first 6 posttransplant months: AUC(0-12) at 6 and 180 days after transplantation was 23.3 +/- 10.8 and 40 +/- 11.6 mg*h/L (P = .003). MPA concentrations 3 and 4 hours after MMF intake were the individual time points that best correlated with the full MPA AUC (r = 0.8 and 0.79; P < .001). The abbreviated MPA AUC (0-4 hours) correlated reasonably with the full AUC (r = 0.87; P < .001). Finally, a significant reduction in CsA dose during the first 6 posttransplant months (P < .001) matched the significant increases in both MPA C0 and full MPA AUC, thus demonstrating the interaction of the 2 immunosuppressive drugs. These observations suggest the need for therapeutic drug monitoring when adjusting the dose of MMF in children.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0041-1345
|
pubmed:author |
pubmed-author:CardilloMM,
pubmed-author:Dello StrologoLL,
pubmed-author:EdefontiAA,
pubmed-author:FerraressoMM,
pubmed-author:GhioLL,
pubmed-author:GianoglioBB,
pubmed-author:GinevriFF,
pubmed-author:MurerLL,
pubmed-author:PerfumoFF,
pubmed-author:TirelliSS,
pubmed-author:ValenteUU,
pubmed-author:ViganòS MSM,
pubmed-author:ZacchelloGG
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
856-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15848555-Child,
pubmed-meshheading:15848555-Cyclosporine,
pubmed-meshheading:15848555-Dose-Response Relationship, Drug,
pubmed-meshheading:15848555-Drug Interactions,
pubmed-meshheading:15848555-Drug Monitoring,
pubmed-meshheading:15848555-Humans,
pubmed-meshheading:15848555-Kidney Transplantation,
pubmed-meshheading:15848555-Metabolic Clearance Rate,
pubmed-meshheading:15848555-Mycophenolic Acid,
pubmed-meshheading:15848555-Postoperative Period
|
pubmed:year |
2005
|
pubmed:articleTitle |
Mycophenolate mofetil pharmacokinetic monitoring in pediatric kidney transplant recipients.
|
pubmed:affiliation |
Pediatric Nephrology Unit, Pediatric Department, Ospedale Maggiore-Policlinico, IRCCS, Milan, Italy. lucianaghio@hotmail.com
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|